Inspira Technologies (Nasdaq:IINN) announced today that it plans to unveil its new Inspira ART line of medical devices. Ra’anana, Israel-based Inspira plans to debut the devices at the Extracorporeal Life Support Organization (ELSO) Conference in Seattle. The line of devices includes the ART100 cardio-pulmonary bypass (CPB) device for patients undergoing CPB procedures. Additionally, the company has […]
Inspira Technologies
Inspira submits cardio-pulmonary bypass device for FDA clearance
Inspira Technologies (Nasdaq:IINN) announced that it submitted its Inspira ART100 cardio-pulmonary bypass device for FDA clearance. Ra’anana, Israel-based Inspira designed the system to transform external breathing, empowering breathing without lungs. The company anticipates potential clearance for the system in the first half of 2024. ART100’s bid for 510(k) clearance is backed by a comprehensive usability […]
Inspira Technologies appoints new chief medical officer
Inspira Technologies this week announced it appointed Adi Rizansky Nir as chief medical officer. Nir will play a critical role in overseeing and guiding Inspira’s medical operations and strategic initiatives. She will collaborate closely with the company’s executive leadership team, medical stage and scientific advisory board to develop and implement innovative strategies that enhance patient […]
Inspira unveils Liby ECMO system for treating heart, lung failure
Inspira Technologies (Nasdaq:IINN) today introduced the Liby system for extracorporeal membrane oxygenation (ECMO) treatment. Ra’anana, Israel-based Inspira expects its Liby system, currently under development, to be submitted to the FDA for regulatory approval during the first half of 2023. ECMO technology pumps, oxygenates and removes carbon dioxide from blood for patients whose lungs can’t provide […]